MedEquity Capital

MedEquity Capital is a private equity firm located in Waltham, Massachusetts, established in 1999. The firm specializes in investing in small and lower middle market healthcare businesses, focusing on sectors such as healthcare services, outsourcing, distribution, specialty pharmacy, and technology-enabled services. MedEquity Capital aims to support the growth and development of these companies through strategic investments and operational improvements.

Tom Beausejour

Principal

Leland Garrahan

Vice President

Angela Iaria

Director, Finance

Jeff Ward

Partner and Co-Founder

Jeffrey T. Ward

Partner

14 past transactions

Cardiovascular Associates of America

Private Equity Round in 2024
Cardiovascular Associates of America is a company dedicated to enhancing cardiology practices by offering growth funding and administrative support. It implements a physician-centered practice management model that unites leaders in heart and vascular care, fostering collaboration among cardiovascular physicians. This collective effort aims to improve patient outcomes, reduce costs, and drive clinical innovation in the management of cardiovascular health. By creating a network with a shared mission, the company seeks to optimize the delivery of care and elevate the quality of services provided to patients.

MAX Surgical Specialty Management

Private Equity Round in 2023
MAX Surgical Specialty Management is a healthcare company based in Hackensack, New Jersey, specializing in oral and maxillofacial surgery. It operates as a management services organization that collaborates with leading oral and maxillofacial surgery practices. The company focuses on enhancing clinical experiences and fostering strategic growth while ensuring efficient daily operations tailored to the specific needs of these practices. By partnering with premier OMS practices, MAX Surgical Specialty Management aims to provide comprehensive support that enables scalability and effectiveness in delivering surgical care.

Riverside Oral Surgery

Private Equity Round in 2022
Riverside Oral Surgery is a dental clinic located in River Edge, New Jersey, specializing in oral and maxillofacial surgery. The clinic is staffed by highly trained surgeons who manage a variety of issues related to the mouth, teeth, and facial regions. Services offered include dental implant surgery, wisdom tooth removal, and corrective jaw surgery, along with the diagnosis and treatment of facial pain, oral pathology, and facial injuries. The surgical team consists of experienced assistants who provide IV sedation and surgical support in a state-of-the-art facility, ensuring optimal patient comfort and safety. All staff members are well-versed in perioperative patient management and certified in cardiac life support, allowing for continuous monitoring of patients during and after procedures. Riverside Oral Surgery is committed to delivering comprehensive and compassionate care for all oral health needs.

Qler Solutions

Series B in 2021
Qler Solutions LLC is a company based in Reston, Virginia, founded in 2016. It specializes in providing an on-demand solution for the delivery of psychiatric care across multiple settings, including emergency departments, medical-surgical floors, behavioral inpatient facilities, clinics, and nursing homes throughout the United States. By leveraging innovative technology, Qler Solutions aims to enhance access to psychiatric services, addressing the growing demand for mental health care in diverse healthcare environments.

Leadscope

Private Equity Round in 2020
Leadscope is a company that specializes in chemoinformatics, providing decision support tools designed for scientists involved in drug discovery. It develops an application that offers access to a variety of research data, including toxicity databases and data management solutions. In addition, Leadscope delivers services such as in silico toxicity assessments, data mining, high-throughput screening analysis, lead optimization, and compound acquisition. The company serves a diverse clientele, including national laboratories, pharmaceutical and biotechnology firms, chemical companies, consumer products organizations, and regulatory agencies across the United States, Canada, and Europe.

Tristan Medical

Private Equity Round in 2015
Tristan Medical is a healthcare provider that specializes in delivering a range of medical services, including primary care, urgent care, and occupational health services. The company operates healthcare centers designed to offer comprehensive medical care under one roof, ensuring convenience for patients. In addition to primary and urgent care, Tristan Medical provides services such as compliance physicals, pre-employment drug screenings, and drug and alcohol testing programs. The organization is dedicated to treating each patient with compassion and aims to deliver high-quality medical services tailored to the needs of the community.

LiceGuard

Acquisition in 2012
LiceGuard is a company specializing in the manufacture of nontoxic and pesticide-free products designed for the treatment and prevention of lice. Dedicated to providing safe alternatives to traditional lice treatments, LiceGuard's products are free from harmful chemicals, making them suitable for use on children. The company focuses on creating effective solutions that address the frustration associated with lice infestations while prioritizing natural and non-toxic methods.

Crescent Healthcare

Private Equity Round in 2004
Crescent Healthcare is a California-based distributor of specialty pharmaceutical products, specializing in chronic infusion therapy services. The company operates eight pharmacy locations in California and Florida, catering to patients across the nation. Crescent Healthcare dispenses and administers a range of specialty pharmaceuticals in both clinic and home settings, including intravenous immunoglobulin (IVIG) therapy, which treats immune deficiencies and autoimmune disorders by infusing proteins that combat bacteria, viruses, and antigens. Through its services, Crescent Healthcare aims to provide essential therapies to patients requiring specialized medical care.

OnCURE Medical

Debt Financing in 2003
OnCURE Medical, founded in 1998, operates a network of radiation cancer treatment centers focused on providing comprehensive radiation oncology services. The company is dedicated to delivering high-quality care to cancer patients, utilizing advanced technologies in radiation treatment. OnCURE collaborates with affiliated radiation oncologists to ensure effective patient care, without owning or managing physician practices. By offering a range of radiation therapy options and medical support, OnCURE Medical helps patients navigate the complexities of cancer treatment and the healing process.

Decision Management International

Venture Round in 2001
Decision Management International, Inc. (DMI) is a prominent provider of software products and consulting services tailored for companies in FDA-regulated industries. Established in 1993, DMI specializes in developing paperless solutions for current Good Manufacturing Practices (cGMP) operations, effectively reducing operational complexities and costs for clients in the pharmaceutical, biotechnology, and medical device sectors. The company offers a fully integrated software suite that addresses documentation compliance procedures, which is critical for organizations that must adhere to stringent regulatory requirements. DMI's innovative product suite includes solutions for document authoring, archiving, and electronic batch records, all designed to streamline compliance reporting. As a Microsoft Certified Partner, DMI has built a strong reputation for its consulting expertise and advanced software applications, leading to sustained client engagements and a growing portfolio of new customers across the U.S., Canada, and Europe.

Heartlab

Private Equity Round in 2001
Heartlab is a privately held company that develops and integrates cardiac imaging software and network systems for cardiology centers.

OpenNetwork Technologies

Venture Round in 2000
OpenNetwork makes software for managing user identity over the Web. The company's Universal Identity Platform (Universal IdP) product integrates with existing Lightweight Directory Access Protocol (LDAP) directory services, such as Microsoft's Active Directory. It is designed to work with Microsoft's .Net Framework and .Net Web Services, permitting Web applications and other resources to be secured and managed without needing to duplicate network policy and user identity information, according to OpenNetwork.

VelQuest

Private Equity Round in 2000
VelQuest Corporation is a leading provider of lab execution and instrument data capture software tailored for pharmaceutical and medical device manufacturers. The company specializes in developing compliance management systems that automate data acquisition, compliance documentation, storage, and retrieval processes. By offering solutions for lab information management, lab execution, and electronic data capture, VelQuest replaces outdated manual documentation methods, thereby enhancing operational efficiency and minimizing risks associated with Good Manufacturing Practice (GMP) compliance. Additionally, the company offers a range of services, including planning, consultation, implementation, validation, customer education, and support, ensuring that clients can effectively integrate and utilize their systems.

TransMedics

Series A in 2000
TransMedics Group, Inc., established in 1998 and based in Andover, Massachusetts, is a commercial-stage medical technology company specializing in transforming organ transplant therapy for end-stage organ failure patients worldwide. The company's core product, the Organ Care System (OCS), is a portable, innovative technology that maintains donor organs outside the body in a near-physiologic state, replicating human-like conditions. This system includes OCS LUNG and OCS Heart, designed to preserve and optimize lungs and hearts respectively during transport, allowing for better assessment and improvement of organ condition. TransMedics also offers clinical services to enhance transplant volume, improve outcomes, and reduce learning curves for healthcare providers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.